DOCSLIB.ORG

Pathology of Fatty Liver Disease

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Pathology of Fatty Liver Disease Modern Pathology (2007) 20, S40–S48 & 2007 USCAP, Inc All rights reserved 0893-3952/07 $30.00 www.modernpathology.org Pathology of fatty liver disease Elizabeth M Brunt Department of Pathology, Saint Louis University School of Medicine, St Louis, MO, USA Fatty liver disease is currently recognized as a common cause of liver test elevation, paralleling the worldwide ‘epidemic’ of obesity in adults and children. In many clinical practices, there is recognition that liver biopsy evaluation is the only means of diagnosis (or exclusion) of fatty liver disease, as neither laboratory tests nor imaging studies to date can provide complete data related to amount of steatosis, inflammation, liver cell injury, fibrosis, and architectural remodeling. Liver biopsy evaluation also provides a means of ‘grading and staging’ the lesions of fatty liver disease and of detecting clinically unsuspected processes. Liver biopsy evaluation is often the primary end point in clinical trials of treatment, thus, standardization of diagnosis and methods of grading and staging have become important. In this review, these concepts as well as the pathophysiologic bases for them are discussed. Modern Pathology (2007) 20, S40–S48. doi:10.1038/modpathol.3800680 Keywords: fatty liver disease; insulin resistance; grading; staging The normal adult human liver may have up to 5% of Nonalcoholic fatty liver disease (NAFLD) its mass as lipid. The size of triglyceride droplets (macrovesicular or microvesicular) may be a clue to Background the underlying cause of the accumulation. When The significance of excess fat accumulation in the discussing ‘fatty liver disease’, most often we are liver was recognized by pathologists in the 19th referring to diseases that are characterized by century. Associations of hepatic steatosis and cirro- predominantly large droplet steatosis (macrovesi- hosis with obesity, diabetes and alcohol have been cular steatosis), or mixed large and small droplet documented in numerous large studies of American steatosis. Small droplets that do not fill the entire and European pathologists in the 20th century. hepatocyte are usually included in the macrovesi- Although not the first to use the term, credit is due cular category. Several primary liver diseases, such to the study from the Mayo Clinic published in 1980 as hepatitis C and Wilson disease, hepatocellular for establishing the moniker ‘NASH’ in the nomen- adenoma and carcinoma, and certain drugs and clature of fatty liver disease.1 In this study, Ludwig toxins, such as steroids and alcohol, commonly et al1 carefully established the nonalcoholic nature show these forms of steatosis (Figure 1a). In contrast, of the 20 subjects with liver biopsies; 90% were ‘true’ microvesicular steatosis consists of much obese, 65% were women, 25% were diabetic and/or smaller, uniform fat droplets dispersed throughout hyperlipidemic, and 15% had hypertension. The the hepatocyte, and often requires special stains subjects had been accrued based on a liver biopsy such as oil red O to detect (Figure 1b). This latter with features that had been characterized as ‘alco- form is a manifestation of severe, recent liver injury, hol-like’. Over the course of the next decade, the such as in Reye’s syndrome and acute fatty liver of concept of NAFLD became accepted, in no small pregnancy and other processes of deranged mito- part due to pathologists’ contributions in clinico- chondrial b oxidation. pathologic studies. Today, we recognize that hepatic steatosis cannot be ignored as a mere histologic oddity, but rather is a significant finding or marker for potentially progressive liver disease. Most often, we see steatosis in the setting of alcohol-related liver disease, and hepatitis C (especially genotype 3), and in NAFLD and nonalcoholic steatohepatitis (NASH). Correspondence: Dr EM Brunt, MD, Department of Pathology, In addition, in the setting of liver transplantation, Saint Louis University School of Medicine, 4th Floor, FDT 3635 large amounts of large droplet fat have been Vista Avenue, St Louis, MO 63110, USA. E-mail: [email protected] associated with initial poor function of the liver Received 14 July 2006; accepted 26 July 2006 graft. Pathology of fatty liver disease EM Brunt S41 Figure 1 (a) Steatosis can be seen in varying amounts in a variety of liver diseases. The etiology of the steatosis may be due to a toxin, hepatitis C viral infection or host factors, but often cannot be determined by histologic evaluation. This is an example of steatosis, large and small droplet type, in hepatitis C in an overweight, diabetic individual. (b) Microvesicular steatosis is often initially considered as swollen, ‘ballooned’ hepatocytes. As shown in this example of acute fatty liver of pregnancy, the hepatocytes are enlarged and the cytoplasm is reticulated by the small aggregates of steatosis. Because of the significance of the clinical situations in which microvesicular steatosis is the dominant finding, stains on frozen sections are highly recommended for confirmation (photograph courtesy of Dr Linda Ferrell). The epidemic of obesity throughout the world has study, 21% of 742 such patients were found to have brought awareness of NAFLD to the forefront of NAFLD. Each of these types of studies have hepatology and medicine in the past quarter cen- recognized drawbacks and liver tissue evaluation tury. Currently, NAFLD is ‘billed’ as the most remains the ‘gold standard’ in the clinico-pathologic common form of chronic liver disease for adults in diagnosis of NAFLD for confirmation (or exclusion) the United States and is growing to be such in Asia. of the diagnosis, for distinguishing NAFLD and The problem is now recognized in both adults and NASH, and to establish severity of inflammation children. In all populations, obese and diabetic and fibrosis.8 subjects are at higher risk than lean, nondiabetic Studies have confirmed that routine clinical tests individuals. It is unethical and impractical to per- alone may misdiagnose (overdiagnose) NASH in a form population screening with liver biopsies, so significant proportion of cases,9 and that not all several methods have been used to determine ‘unexplained’ liver test abnormalities are the result prevalence of NAFLD. Three cited studies are based of fatty liver disease.10 In Skelly et al’s10 study, liver on the data collected from the third National Health biopsy made a clinically significant and previously and Nutrition Evaluation Survey;2–4 all three studied unsuspected diagnosis in 13% of cases, confirmed ALT values in nonalcoholic subjects without ser- cryptogenic liver disease in 9% and documented ologic markers of liver disease; some additionally normal liver in 6%. Recent reports of liver disease in included values for AST2 and GGT,3 and only one diabetics also confirm the value of tissue evaluation specifically excluded diabetics.4 These studies to identify entities other than fat, such as glycogenic found ‘unexplained’ elevated liver tests in US adults hepatopathy, characterized by diffuse glycogeno- in 5.45, 23 and 2.8%, respectively. The latter study sis,11 and diabetic hepatosclerosis, which consists of showed that 68% of those could be accounted for by dense perisinusoidal fibrosis and basement mem- increased body mass index (BMI).4 An Italian brane deposition12 (Figure 2a and b). Neither of population survey based on ultrasound evaluation these entities is characterized by significant steato- of a cohort of 257 nondiabetic adults with no sis. These studies also emphasize the value of serologic evidence of liver disease showed evidence adequate clinical information, as both of these of steatosis (‘bright liver’) in 58%.5 This study also entities occur in the setting of insulin-dependent showed that the risk of steatosis was related to diabetes rather than obesity. obesity and alcohol use. Another imaging study6 that measured hepatic triglyceride content in a multiethnic cohort of 2287 subjects in the US Role of Liver Biopsy documented steatosis in 30% of subjects; interest- ingly, 79% of these subjects had normal ALT values. Histologic evaluation has also played an important The ethnic distribution of steatosis reflected the role in broadening the concept of NAFLD from a well-documented ethnic distribution of NAFLD- liver disease of only obese individuals with elevated related cirrhosis: Hispanic4Caucasian4African ALT, to an entity that can involve lean indivi- American. A novel approach to detect prevalence duals,13,14 or subjects with normal ALT values as has come from evaluation of newly diagnosed liver well.15 Most studies of NAFLD focus on subjects in disease patients in a large clinic setting;7 in this whom other forms of liver disease have been Modern Pathology (2007) 20, S40–S48 Pathology of fatty liver disease EM Brunt S42 Figure 2 (a) Glycogenic hepatopathy. The hepatocyte cytoplasm is markedly expanded by excess glycogen, imparting a ‘glassy’ appearance. The parenchyma is diffusely involved. Small amounts of steatosis may also be present. (b) Diabetic hepatosclerosis, with patches of dense perisinusoidal fibrosis (trichrome stain). excluded, but some have documented NAFLD/ and thus in ‘grade’ and ‘stage’ have been shown in NASH in subjects with concurrent chronic liver recent studies.28,29 As in all liver diseases, the type disease.16–18 A feature that often leads to diagnostic of liver biopsy (for instance, wedge biopsy, intra- difficulties for clinicians is the presence of abnormal operative biopsy, etc) available for evaluation and ANA, ASMA and
Load more

Recommended publications
  • Impact of HIV on Gastroenterology/Hepatology
    Core Curriculum: Impact of HIV on Gastroenterology/Hepatology AshutoshAshutosh Barve,Barve, M.D.,M.D., Ph.D.Ph.D. Gastroenterology/HepatologyGastroenterology/Hepatology FellowFellow UniversityUniversityUniversity ofofof LouisvilleLouisville Louisville Case 4848 yearyear oldold manman presentspresents withwith aa historyhistory ofof :: dysphagiadysphagia odynophagiaodynophagia weightweight lossloss EGDEGD waswas donedone toto evaluateevaluate thethe problemproblem University of Louisville Case – EGD Report ExtensivelyExtensively scarredscarred esophagealesophageal mucosamucosa withwith mucosalmucosal bridging.bridging. DistalDistal esophagealesophageal nodulesnodules withwithUniversity superficialsuperficial ulcerationulceration of Louisville Case – Esophageal Nodule Biopsy InflammatoryInflammatory lesionlesion withwith ulceratedulcerated mucosamucosa SpecialSpecial stainsstains forfor fungifungi revealreveal nonnon-- septateseptate branchingbranching hyphaehyphae consistentconsistent withwith MUCORMUCOR University of Louisville Case TheThe patientpatient waswas HIVHIV positivepositive !!!! University of Louisville HAART (Highly Active Anti Retroviral Therapy) HIV/AIDS Before HAART After HAART University of Louisville HIV/AIDS BeforeBefore HAARTHAART AfterAfter HAARTHAART ImmuneImmune dysfunctiondysfunction ImmuneImmune reconstitutionreconstitution OpportunisticOpportunistic InfectionsInfections ManagementManagement ofof chronicchronic ¾ Prevention diseasesdiseases e.g.e.g. HepatitisHepatitis CC ¾ Management CirrhosisCirrhosis NeoplasmsNeoplasms
    [Show full text]
  • Evaluation of Abnormal Liver Chemistries
    ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries Paul Y. Kwo, MD, FACG, FAASLD1, Stanley M. Cohen, MD, FACG, FAASLD2, and Joseph K. Lim, MD, FACG, FAASLD3 1Division of Gastroenterology/Hepatology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA; 2Digestive Health Institute, University Hospitals Cleveland Medical Center and Division of Gastroenterology and Liver Disease, Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; 3Yale Viral Hepatitis Program, Yale University School of Medicine, New Haven, Connecticut, USA. Am J Gastroenterol 2017; 112:18–35; doi:10.1038/ajg.2016.517; published online 20 December 2016 Abstract Clinicians are required to assess abnormal liver chemistries on a daily basis. The most common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase and bilirubin. These tests should be termed liver chemistries or liver tests. Hepatocellular injury is defined as disproportionate elevation of AST and ALT levels compared with alkaline phosphatase levels. Cholestatic injury is defined as disproportionate elevation of alkaline phosphatase level as compared with AST and ALT levels. The majority of bilirubin circulates as unconjugated bilirubin and an elevated conjugated bilirubin implies hepatocellular disease or cholestasis. Multiple studies have demonstrated that the presence of an elevated ALT has been associated with increased liver-related mortality. A true healthy normal ALT level ranges from 29 to 33 IU/l for males, 19 to 25 IU/l for females and levels above this should be assessed. The degree of elevation of ALT and or AST in the clinical setting helps guide the evaluation.
    [Show full text]
  • Perturbation of Mitochondrial Dynamics in Alcoholic Liver Disease
    EXTENDED ABSTRACT Journal of the World Mitochondria Society Vol. 2, Issue n°2 DOI 10.18143/JWMS_v2i2_1948 Perturbation of mitochondrial dynamics in alcoholic liver disease Elena PALMA(1, 2), Antonio RIVA(1, 2), Satvinder MUDAN(3), Nikolai MANYAKIN(3), Dawn MORRISON(3), Christophe MORENO(4, 5), Delphine DEGRÉ(4, 5), Eric TREPO(4, 5), Pau SANCHO- BRU(6, 7), Jose ALTAMIRANO(6, 8), Juan CABALLERIA(6, 7), Gemma ODENA(9), Ramon BATALLER(9), Roger WILLIAMS(1, 2), Shilpa CHOKSHI(1, 2) 1Institute of Hepatology, Foundation for Liver Research, London, United Kingdom. 2King’s College London, Faculty of Life Sciences and Medicine, London, United Kingdom. 3The London Clinic, London, United Kingdom. 4CUB Hôpital Erasme, Department of Gastroenterology, Hepatopancreatology and Digestive Oncology, Université Libre de Bruxelles, Brussels, Belgium. 5Laboratory of Experimental Gastroenterology, Université Libre de Bruxelles, Brussels, Belgium. 6Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. 7Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain. 8Liver Unit -Internal Medicine Department Vall d'Hebron University Hospital. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain. 9Division of Gastroenterology and Hepatology, Departments of Medicine and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. Corresponding author: Elena Palma Institute of Hepatology, Foundation for Liver Research 111 Coldharbour Lane, London, SE5 9NT (UK) [email protected] Abstract Alcoholic Liver Disease (ALD) is a global issue that causes increasing number of deaths annually. In the complex pathogenesis of ALD the involvement of mitochondria is well established and gross morphological alterations (mega-mitochondria) in the liver biopsies of patients are recognised as hallmarks of ALD.
    [Show full text]
  • Viral Hepatitis Testing Effective Date: January 1, 2012
    Viral Hepatitis Testing Effective Date: January 1, 2012 Scope This guideline provides guidance for the use of laboratory tests to diagnose acute and chronic viral hepatitis in adults (> 19 years) in the primary care setting. General Considerations for Ordering Laboratory Tests Prior to ordering tests for hepatitis, consider the patient’s history, age, risk factors (see below), hepatitis vaccination status, and any available previous hepatitis test results. Risk Factors for Viral Hepatitis include: • Substance use (includes sharing drug snorting, smoking or injection equipment) • High-risk sexual activity or sexual partner with viral hepatitis • Travel to or from high-risk hepatitis endemic areas or exposure during a local outbreak • Immigration from hepatitis B and/or C endemic countries • Household contact with an infected person especially if personal items (e.g., razors, toothbrushes, nail clippers) are shared • Recipient of unscreened blood products* • Needle-stick injury or other occupational exposure (e.g., healthcare workers) • Children born to mothers with chronic hepatitis B or C infection • Attendance at daycare • Contaminated food or water (hepatitis A only) • Tattoos and body piercing • History of incarceration • HIV or other sexually transmitted infection • Hemodialysis *screening of donated blood products for hepatitis C (anti-HCV) began in 1990 in Canada.1 Types of Viral Hepatitis Hepatitis A: causes acute but not chronic hepatitis Hepatitis B: causes acute and chronic hepatitis Hepatitis C: causes chronic hepatitis but rarely manifests as acute hepatitis Hepatitis D: rare and only occurs in patients infected with hepatitis B Hepatitis E: clinically similar to hepatitis A, mostly restricted to endemic areas and occasionally causes chronic infection in immunosuppressed people Others: e.g.
    [Show full text]
  • Steatosis in Hepatitis C: What Does It Mean? Tarik Asselah, MD, Nathalie Boyer, MD, and Patrick Marcellin, MD*
    Steatosis in Hepatitis C: What Does It Mean? Tarik Asselah, MD, Nathalie Boyer, MD, and Patrick Marcellin, MD* Address Steatosis *Service d’Hépatologie, Hôpital Beaujon, Mechanisms of steatosis 100 Boulevard du Général Leclerc, Clichy 92110, France. Hepatic steatosis develops in the setting of multiple E-mail: [email protected] clinical conditions, including obesity, diabetes mellitus, Current Hepatitis Reports 2003, 2:137–144 alcohol abuse, protein malnutrition, total parenteral Current Science Inc. ISSN 1540-3416 Copyright © 2003 by Current Science Inc. nutrition, acute starvation, drug therapy (eg, corticosteroid, amiodarone, perhexiline, estrogens, methotrexate), and carbohydrate overload [1–4,5••]. Hepatitis C and nonalcoholic fatty liver disease (NAFLD) are In the fed state, dietary triglycerides are processed by the both common causes of liver disease. Thus, it is not surprising enterocyte into chylomicrons, which are secreted into the that they can coexist in the same individual. The prevalence of lymph. The chylomicrons are hydrolyzed into fatty acids by steatosis in patients with chronic hepatitis C differs between lipoprotein lipase. These free fatty acids are transported to the studies, probably reflecting population differences in known liver, stored in adipose tissue, or used as energy sources by risk factors for steatosis, namely overweight, diabetes, and muscles. Free fatty acids are also supplied to the liver in the dyslipidemia. The pathogenic significance of steatosis likely form of chylomicron remnants, which are then hydrolyzed by differs according to its origin, metabolic (NAFLD or non- hepatic triglyceride lipase. During fasting, the fatty acids sup- alcoholic steatohepatitis) or virus related (due to hepatitis C plied to the liver are derived from hydrolysis (mediated by a virus genotype 3).
    [Show full text]
  • Review Article Alcohol Induced Liver Disease
    J Clin Pathol: first published as 10.1136/jcp.37.7.721 on 1 July 1984. Downloaded from J Clin Pathol 1984;37:721-733 Review article Alcohol induced liver disease KA FLEMING, JO'D McGEE From the University of Oxford, Nuffield Department ofPathology, John Radcliffe Hospital, Oxford OX3 9DU, England SUMMARY Alcohol induces a variety of changes in the liver: fatty change, hepatitis, fibrosis, and cirrhosis. The histopathological appearances of these conditions are discussed, with special atten- tion to differential diagnosis. Many forms of alcoholic liver disease are associated with Mallory body formation and fibrosis. Mallory bodies are formed, at least in part, from intermediate filaments. Associated changes in intermediate filament organisation in alcoholic liver disease also occur. Their significance in the pathogenesis of hepatocyte death may be related to abnormalities in messenger RNA function. The mechanisms underlying hepatic fibrogenesis are also discussed. Although alcohol has many effects on the liver, all formed after some period of alcohol abstinence, except cirrhosis are potentially reversible on cessa- alcohol related changes may not be seen. Accord- tion of alcohol ingestion. Cirrhosis is irreversible ingly, we shall consider the morphological changes and usually ultimately fatal. It is therefore important associated with alcohol abuse under the headings in to determine what factors are responsible for Table 1. development of alcohol induced cirrhosis, especially In the second part, the pathogenesis of alcohol since only 17-30% of all alcoholics become' cirrho- induced liver disease will be discussed, but this will tic.' This is of some urgency now, since there has deal only with the induction of alcoholic hepatitis, been an explosive increase in alcohol consumption fibrosis, and cirrhosis-that is, chronic alcoholic http://jcp.bmj.com/ in the Western World, particularly affecting young liver disease-and not with fatty change, for two people, resulting in a dramatic increase in the inci- reasons.
    [Show full text]
  • An Abridged Compendium of Words. a Discussion of Them and Opinions About Them
    DERMATOLOGY PRACTICAL & CONCEPTUAL www.derm101.com Dermatopathology: An abridged compendium of words. A discussion of them and opinions about them. Part 6 (I-L) Bruce J. Hookerman1 1 Dermatology Specialists, Bridgeton, Missouri, USA Citation: Hookerman BJ. Dermatopathology: An abridged compendium of words. A discussion of them and opinions about them. Part 6 (I-L). Dermatol Pract Concept. 2014;4(4):1. http://dx.doi.org/10.5826/dpc.0404a01 Copyright: ©2014 Hookerman. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Corresponding author: Bruce J. Hookerman, M.D., 12105 Bridgeton Square Drive, St. Louis, MO 63044, USA. Email: [email protected] – I – term “id reaction” only for a spongiotic dermatitis manifested by tiny vesicles on the hands of patients with florid dermato- ICHTHYOSIS: a generic term for skin conditions character- phytosis at another site, usually the feet, or for an analogue ized by what are said to be fishlike scales, i.e., scales that are of that phenomenon such as widespread vesicles that appear broad and polygonal with free edges, as are seen in ichthyosis subsequent to injudicious treatment, i.e., with Gentian violet vulgaris (and its look-alike, acquired ichthyosis), X-linked (known sardonically in times past as “Gentian violent”) of ichthyosis, and lamellar ichthyosis. Conditions reputed to be an exuberant spongiotic dermatitis, usually on the feet, such ichthyosis, such as ichthyosis hystrix and ichthyosis linearis as an allergic contact dermatitis. A time-honored explana- circumflexa, do not qualify because they are not associated tion for an “id” reaction is hematogenous dissemination of with broad polygonal scales.
    [Show full text]
  • Genetic Basis of Simple and Complex Traits with Relevance to Avian Evolution
    Genetic basis of simple and complex traits with relevance to avian evolution Małgorzata Anna Gazda Doctoral Program in Biodiversity, Genetics and Evolution D Faculdade de Ciências da Universidade do Porto 2019 Supervisor Miguel Jorge Pinto Carneiro, Auxiliary Researcher, CIBIO/InBIO, Laboratório Associado, Universidade do Porto Co-supervisor Ricardo Lopes, CIBIO/InBIO Leif Andersson, Uppsala University FCUP Genetic basis of avian traits Nota Previa Na elaboração desta tese, e nos termos do número 2 do Artigo 4º do Regulamento Geral dos Terceiros Ciclos de Estudos da Universidade do Porto e do Artigo 31º do D.L.74/2006, de 24 de Março, com a nova redação introduzida pelo D.L. 230/2009, de 14 de Setembro, foi efetuado o aproveitamento total de um conjunto coerente de trabalhos de investigação já publicados ou submetidos para publicação em revistas internacionais indexadas e com arbitragem científica, os quais integram alguns dos capítulos da presente tese. Tendo em conta que os referidos trabalhos foram realizados com a colaboração de outros autores, o candidato esclarece que, em todos eles, participou ativamente na sua conceção, na obtenção, análise e discussão de resultados, bem como na elaboração da sua forma publicada. Este trabalho foi apoiado pela Fundação para a Ciência e Tecnologia (FCT) através da atribuição de uma bolsa de doutoramento (PD/BD/114042/2015) no âmbito do programa doutoral em Biodiversidade, Genética e Evolução (BIODIV). 2 FCUP Genetic basis of avian traits Acknowledgements Firstly, I would like to thank to my all supervisors Miguel Carneiro, Ricardo Lopes and Leif Andersson, for the demanding task of supervising myself last four years.
    [Show full text]
  • Prevention & Control of Viral Hepatitis Infection
    Prevention & Control of Viral Hepatitis Infection: A Strategy for Global Action © World Health Organization 2011. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Table of contents Disease burden 02 What is viral hepatitis? 05 Prevention & control: a tailored approach 06 Global Achievements 08 Remaining challenges 10 World Health Assembly: a mandate for comprehensive prevention & control 13 WHO goals and strategy
    [Show full text]
  • Acute Liver Failure J G O’Grady
    148 Postgrad Med J: first published as 10.1136/pgmj.2004.026005 on 4 March 2005. Downloaded from REVIEW Acute liver failure J G O’Grady ............................................................................................................................... Postgrad Med J 2005;81:148–154. doi: 10.1136/pgmj.2004.026005 Acute liver failure is a complex multisystemic illness that account for most cases, but a significant number of patients have no definable cause and are evolves quickly after a catastrophic insult to the liver classified as seronegative or of being of indeter- leading to the development of encephalopathy. The minate aetiology. Paracetamol is the commonest underlying aetiology and the pace of progression strongly cause in the UK and USA.2 Idiosyncratic reac- tions comprise another important group. influence the clinical course. The commonest causes are paracetamol, idiosyncratic drug reactions, hepatitis B, and Viral seronegative hepatitis. The optimal care is multidisciplinary ALF is an uncommon complication of viral and up to half of the cases receive liver transplants, with hepatitis, occurring in 0.2%–4% of cases depend- ing on the underlying aetiology.3 The risk is survival rates around 75%–90%. Artificial liver support lowest with hepatitis A, but it increases with the devices remain unproven in efficacy in acute liver failure. age at time of exposure. Hepatitis B can be associated with ALF through a number of ........................................................................... scenarios (table 2). The commonest are de novo infection and spontaneous surges in viral repli- cation, while the incidence of the delta virus cute liver failure (ALF) is a complex infection seems to be decreasing rapidly. multisystemic illness that evolves after a Vaccination should reduce the incidence of Acatastrophic insult to the liver manifesting hepatitis A and B, while antiviral drugs should in the development of a coagulopathy and ameliorate replication of hepatitis B.
    [Show full text]
  • Elevated Levels of the Steroidogenic Factor 1 Are Associated with Over
    European Journal of Endocrinology (2012) 166 941–949 ISSN 0804-4643 CASE REPORT Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour Anne Hege Straume1,2, Kristian Løva˚s3,4, Hrvoje Miletic5,6, Karsten Gravdal5, Per Eystein Lønning1,2 and Stian Knappskog1,2 1Section of Oncology, Institute of Medicine, University of Bergen, Bergen, Norway, 2Department of Oncology, Haukeland University Hospital, Bergen, Norway, 3Section of Endocrinology, Institute of Medicine, University of Bergen, Bergen, Norway, 4Department of Medicine and 5Section of Pathology, Haukeland University Hospital, Bergen, Norway and 6Department of Biomedicine, University of Bergen, Bergen, Norway (Correspondence should be addressed to S Knappskog who is now at Mohn Cancer Research Laboratory (1M), Haukeland University Hospital, 5021 Bergen, Norway; Email: [email protected]) Abstract Background and objectives: Testicular Leydig cell tumours (LCTs) are rare, steroid-secreting tumours. Elevated levels of aromatase (CYP19 or CYP19A1) mRNA have been previously described in LCTs; however, little is known about the mechanism(s) causing CYP19 over-expression. We report an LCT in a 29-year-old male with elevated plasma oestradiol caused by enhanced CYP19 transcription. Design and methods: First, we measured the intra-tumour expression of CYP19 and determined the use of CYP19 promoters by qPCR. Secondly, we explored CYP19 and promoter II (PII) for gene amplifications and activating mutations in PII by sequencing. Thirdly, we analysed intra-tumour expression of steroidogenic factor 1 (SF-1 (NR5A1)), liver receptor homologue-1 (LRH-1 (NR5A2)) and cyclooxygenase-2 (COX2 (PTGS2)). Finally, we analysed SF-1 for promoter mutations and gene amplifications.
    [Show full text]
  • Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease
    pathogens Article Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study Giuseppe Losurdo 1,2 , Andrea Iannone 1, Antonella Contaldo 1, Michele Barone 1 , Enzo Ierardi 1 , Alfredo Di Leo 1,* and Mariabeatrice Principi 1 1 Section of Gastroenterology, Department of Emergency and Organ Transplantation, University “Aldo Moro” of Bari, 70124 Bari, Italy; [email protected] (G.L.); [email protected] (A.I.); [email protected] (A.C.); [email protected] (M.B.); [email protected] (E.I.); [email protected] (M.P.) 2 Ph.D. Course in Organs and Tissues Transplantation and Cellular Therapies, Department of Emergency and Organ Transplantation, University “Aldo Moro” of Bari, 70124 Bari, Italy * Correspondence: [email protected]; Tel.: +39-080-559-2925 Received: 14 September 2020; Accepted: 21 October 2020; Published: 23 October 2020 Abstract: We performed an epidemiologic study to assess the prevalence of chronic viral hepatitis in inflammatory bowel disease (IBD) and to detect their possible relationships. Methods: It was a single centre cohort cross-sectional study, during October 2016 and October 2017. Consecutive IBD adult patients and a control group of non-IBD subjects were recruited. All patients underwent laboratory investigations to detect chronic hepatitis B (HBV) and C (HCV) infection. Parameters of liver function, elastography and IBD features were collected. Univariate analysis was performed by Student’s t or chi-square test. Multivariate analysis was performed by binomial logistic regression and odds ratios (ORs) were calculated. We enrolled 807 IBD patients and 189 controls. Thirty-five (4.3%) had chronic viral hepatitis: 28 HCV (3.4%, versus 5.3% in controls, p = 0.24) and 7 HBV (0.9% versus 0.5% in controls, p = 0.64).
    [Show full text]